Condition
Ventricular Septal Defects
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00647387Not ApplicableCompletedPrimary
Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study
NCT02552485Completed
Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions
NCT00890799Not ApplicableCompletedPrimary
Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects
NCT00229827TerminatedPrimary
Optimal Timing for Repair of Left to Right Shunt Lesions
Showing all 4 trials